Apures Co., Ltd. (XKON:149300)
38.00
-1.00 (-2.56%)
At close: Feb 13, 2026
Apures Revenue
Apures had revenue of 84.37M KRW in the quarter ending June 30, 2019, a decrease of -35.42%. This brings the company's revenue in the last twelve months to 517.33M, down -0.13% year-over-year. In the year 2018, Apures had annual revenue of 528.64M with 28.45% growth.
Revenue (ttm)
517.33M
Revenue Growth
-0.13%
P/S Ratio
3.34
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2018 | 528.64M | 117.08M | 28.45% |
| Dec 31, 2017 | 411.56M | -32.44M | -7.31% |
| Dec 31, 2016 | 444.00M | -176.76M | -28.47% |
| Dec 31, 2015 | 620.76M | -171.54M | -21.65% |
| Dec 31, 2014 | 792.30M | -216.30M | -21.45% |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ADBiotech | 14.57B |
| Eutilex.Co.,Ltd | 10.54B |
| The Technology | 8.75B |
| Genotech | 7.28B |
| OLIPASS | 5.25B |
| Kainos Medicine | 938.87M |
| Angiolab | 702.62M |
| Epibiotech | 449.62M |